NEW YORK (GenomeWeb News) – As Venaxis prepares a submission to the US Food and Drug Administration for its appendicitis diagnostic test and a full European launch, the company announced this week the completion of the first futility analysis of the test.

As a result, an independent body has recommended a continuation of Venaxis' pivotal clinical trial for the test, called the APPY1 Test. The trial will include a second futility analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."